Search the Newsreel

StemPoint Capital reports 5.0% Surrozen (SRZN) stake via shares and warrants

StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross have collectively reported a beneficial ownership of 5.0% in Surrozen, Inc. (SRZN). This stake includes 273,140 shares of common stock and 329,658 shares issuable upon exercise of Series A, B, and E warrants, …

Pacific Current Group slips again as thin newsflow and a concentrated register keep investors guessing

Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts

Analysts have significantly upgraded their near-term forecasts for Surrozen, Inc. (NASDAQ:SRZN), projecting greatly increased statutory revenues and earnings per share for 2026. While revenue is still expected to decline compared to past performance and lag the wider industry, analysts have reduced their loss estimates …

Pacific Current Group Ltd (PAC) Q2 2024 Earnings Report - Results, Call & Slides

What is HC Wainwright's Estimate for Surrozen Q3 Earnings?

HC Wainwright has revised its Q3 2026 EPS estimate for Surrozen to a loss of $1.33 per share, down from $1.19, while maintaining a "Buy" rating and a $44 price target. Despite the lowered estimate, Surrozen's recent Q2 results significantly surpassed expectations, reporting a …

Surrozen (SRZN): 5AM Ventures group reports 7.8% beneficial ownership stake

5AM Ventures group, including 5AM Ventures VII, L.P., 5AM Partners VII, LLC, Kush Parmar, and Andrew J. Schwab, has reported a beneficial ownership stake of 7.8% in Surrozen, Inc. (SRZN), totaling 968,750 shares as of June 30, 2026. This includes currently held shares and …

CURRENC Group Inc. (CURR) Price Prediction for 2026 to 2031

This article provides price predictions for CURRENC Group Inc. (CURR) from 2027 to 2045, showing a consistent positive trend and increasing potential ROI. It forecasts CURR to reach $4.52 by 2030 and $9.40 by 2045, attributing growth to market adoption and demand. The article …

Why Currency Exchange International Corp stock is sliding today

H.C. Wainwright reiterates Surrozen stock rating at buy, $44 target

H.C. Wainwright has reiterated a buy rating and a $44 price target for Surrozen Inc. (NASDAQ:SRZN) shares, following a significant 168% gain over the past year. The firm is encouraged by the detailed clinical steps for SZN-8141, a lead bifunctional Wnt/anti-VEGF antibody, which is …

Aurrigo International Plc Receives GBP 1.43 Million UK Government Grant

Solid Earnings Reflect Currys' (LON:CURY) Strength As A Business

Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Surrozen Inc (SRZN) has an earnings forecast score of 8.40, placing it 132nd in the Biotechnology & Medical Research industry. Analysts have an average price target of $37.00 for SRZN, with a "Buy" trend based on 5 analysts. The company's expected revenue for the …

CURRENC Group Inc (CURR) Stock News Today

This article provides stock information for CURRENC Group Inc (CURR) on TradingKey. It displays the current stock price, market cap, and indicates that more news, earnings, and analyst ratings for the company will be available soon. The current data shows CURR trading at $3.110, …

CURRENC Group Inc (CURR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for CURRENC Group Inc (CURR), noting that no specific earnings forecast score is currently available, contrasting with the industry average. It highlights a consensus price target of $3.50 based on zero analyst ratings, indicating a 100% upside potential. …

Surrozen (SRZN) warrants expiring 2026 removed from Nasdaq listing

Surrozen, Inc. (SRZN) warrants expiring on August 10, 2026, have been delisted from the Nasdaq Stock Market LLC. This removal was processed under Section 12(b) of the Securities Exchange Act of 1934, following Nasdaq's and SEC's rules. The delisting signifies that the warrants will …

Surrozen (NASDAQ:SRZN) Issues Quarterly Earnings Results, Beats Expectations By $0.88 EPS

Surrozen (NASDAQ:SRZN) announced its quarterly earnings, reporting an EPS loss of $0.41, significantly better than the consensus estimate of ($1.29), and revenue of $5.00 million, surpassing expectations. Despite beating earnings, the stock declined by $0.31 to $21.64. Analysts maintain a "Moderate Buy" rating, but …

Surrozen, Inc. 2Q 2026: Revenue $5M, Net income $50.18M, EPS $(0.41) — 10-Q Summary

Surrozen, Inc. reported its second-quarter 2026 results, showing a significant increase in revenue to $5M, up 408% year-over-year, and net income of $50.18M. This growth was primarily driven by collaboration milestone recognition and noncash fair value gains. The company also highlighted pipeline progress with …

Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update

Surrozen, Inc. (Nasdaq: SRZN) announced its financial results for the second quarter ended June 30, 2026, and provided a business update. The company plans to submit an IND application for SZN-8141 for diabetic macular edema (DME) by the end of Q3 2026 and initiate …

Predicție Preț CURRENC Group Inc. (CURR) 2026-2031

This article provides price predictions for CURRENC Group Inc. (CURR) from 2027 to 2045, showing an expected positive trend and growth in value. It forecasts CURR to reach approximately $3.70 by 2030 and $7.68 by 2045, with potential ROIs increasing significantly over time. The …

Surrozen (NASDAQ: SRZN) swings to $50.2M profit on Boehringer milestone revenue

Currys PLC (CURY.L) Stock Analysis: A Closer Look At Its 13% Upside Potential

Why (SRZN) Price Action Is Critical for Tactical Trading

This article analyzes Surrozen Inc. (NASDAQ: SRZN) focusing on its price action for tactical trading. It highlights mixed sentiment across different timeframes, with positive near-term sentiment potentially eroding a mid-term weak bias within a long-term strong context. The analysis also provides AI-generated institutional trading …

Bruce Marsh Sells 135,051 Shares of Currys (LON:CURY) Stock

Murray Cod Australia Swims Higher (ASX:MCA)—Could This Aquaculture Stock Be Ready to Scale?

Price to earnings forward of Surrozen, Inc. – BOATS:SRZNW

This article provides financial information for Surrozen, Inc. (SRZNW) on TradingView, specifically focusing on its price to earnings forward. It indicates that the market is closed with no recent trades for the company.

Price to sales forward of Surrozen, Inc. – BOATS:SRZNW

This article focuses on the "Price to sales forward" metric for Surrozen, Inc. (SRZNW) on the Blue Ocean Alternative Trade System (BOATS). It provides a snapshot of this financial ratio, indicating its current value and change percentage. The content is presented within the TradingView …

Surrozen Inc (SRZN) Institutional Confidence

Surrozen Inc (SRZN) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 94.38%, showing an 11.10% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.43% of outstanding shares.

CURRENC Group Inc (CURR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of CURRENC Group Inc (CURR), focusing on its support and resistance levels, various technical indicators, and moving averages. It highlights that CURR's stock is currently trading between a resistance level of 3.68 and a support level of 2.68, …

Concurrent Technologies Plc Revenue Breakdown – LSE:CNC

Currys PLC Revenue Breakdown – LSE:CURY

Surrozen Inc (SRZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Surrozen Inc (SRZN), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently ranks 115 out of 385 in the Biotechnology & Medical Research industry with a price …

Surrozen Inc (SRZN) Financial Health: Profitability & Balance Sheet Analysis

Surrozen Inc (SRZN) has an improved financial score of 8.27, ranking 53rd in the Biotechnology & Medical Research industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 408.65% to $5.00M and a net profit increase …

Murray Cod Australia (ASX: MCA): Can Aquna’s Scale-Up Turn Premium Cod Into Cash?